Ambrx Biopharma Cayman, Inc. SEC EDGAR Filings (CIK 0001836056)

SEC EDGAR filings, ownership reports, and insider transactions for Ambrx Biopharma Cayman, Inc..

Industry
Biological Products, (No Disgnostic Substances) (Office Of Life Sciences)
Business address
10975 North Torrey Pines Road, La Jolla, CA, 92037
State of incorporation
Cayman Islands
Fiscal year end
31 December
Former names
Ambrx Biopharma Inc. (to 10 Oct 2023)
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Ambrx Biopharma Cayman, Inc. has filed 164 SEC EDGAR filings since 03 Feb 2021

Latest Filings

Recent SEC filings for Ambrx Biopharma Cayman, Inc. including 25-NSE, SC 13G/A, 15-12G and more.

Form type Document Filing Description Filing date Reporting date File number(s)
25-NSE Open 25-NSE document View SEC filing for 25-NSE 07 Mar 2024 001-40505
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 09 Feb 2024 005-92634
15-12G Open 15-12G document View SEC filing for 15-12G 15-12G 23 Oct 2023 001-40505
S-8 POS Open S-8 POS document View SEC filing for S-8 POS S-8 POS 12 Oct 2023 333-271966
S-8 POS Open S-8 POS document View SEC filing for S-8 POS S-8 POS 12 Oct 2023 333-271005
S-8 POS Open S-8 POS document View SEC filing for S-8 POS S-8 POS 12 Oct 2023 333-264490
S-8 POS Open S-8 POS document View SEC filing for S-8 POS S-8 POS 12 Oct 2023 333-257264
25-NSE Open 25-NSE document View SEC filing for 25-NSE 12 Oct 2023 001-40505
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 Oct 2023 11 Oct 2023 001-40505
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 10 Oct 2023 10 Oct 2023 001-40505
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 10 Oct 2023 005-92634
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Oct 2023 06 Oct 2023 001-40505
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 25 Sep 2023 005-92634
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 25 Sep 2023 18 Sep 2023 001-40505
4 Open 4 document View SEC filing for 4 19 Sep 2023 15 Sep 2023
DEFM14A Open DEFM14A document View SEC filing for DEFM14A DEFM14A 15 Sep 2023 001-40505
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 15 Sep 2023 11 Sep 2023 001-40505
4 Open 4 document View SEC filing for 4 4 06 Sep 2023 01 Sep 2023
3 Open 3 document View SEC filing for 3 3 06 Sep 2023 01 Sep 2023
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Sep 2023 01 Sep 2023 001-40505
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 25 Aug 2023 25 Aug 2023 001-40505
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 09 Aug 2023 30 Jun 2023 001-40505
4 Open 4 document View SEC filing for 4 4 07 Jul 2023 05 Jul 2023
4 Open 4 document View SEC filing for 4 4 07 Jul 2023 05 Jul 2023
4 Open 4 document View SEC filing for 4 4 07 Jul 2023 05 Jul 2023
4 Open 4 document View SEC filing for 4 28 Jun 2023 27 Jun 2023
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMBRX BIOPHARMA INC. 28 Jun 2023 005-92634
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 28 Jun 2023 27 Jun 2023 001-40505
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Jun 2023 18 May 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Jun 2023 07 Jun 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Jun 2023 07 Jun 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Jun 2023 07 Jun 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Jun 2023 07 Jun 2023
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 08 Jun 2023 08 Jun 2023 001-40505
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 May 2023 18 May 2023
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMBRX BIOPHARMA INC. 25 May 2023 005-92634
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 25 May 2023 23 May 2023 001-40505
424B5 Open 424B5 document View SEC filing for 424B5 424B5 25 May 2023 333-271008
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 19 May 2023 18 May 2023
DEFA14A Open DEFA14A document View SEC filing for DEFA14A DEFA14A 18 May 2023 001-40505
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 18 May 2023 18 May 2023 001-40505
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 16 May 2023 15 May 2023 001-40505
S-8 Open S-8 document View SEC filing for S-8 S-8 16 May 2023 333-271966
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 11 May 2023 31 Mar 2023 001-40505
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 05 May 2023 28 Apr 2023
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 05 May 2023 28 Apr 2023
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 04 May 2023 28 Apr 2023 001-40505
EFFECT Open EFFECT document View SEC filing for EFFECT 02 May 2023 333-271008
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 28 Apr 2023 26 Apr 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 28 Apr 2023 26 Apr 2023
CORRESP Open CORRESP document View SEC filing for CORRESP 28 Apr 2023
ARS Open ARS document View SEC filing for ARS ARS 28 Apr 2023 31 Dec 2022 001-40505
DEF 14A Open DEF 14A document View SEC filing for DEF 14A DEF 14A 28 Apr 2023 07 Jun 2023 001-40505
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 27 Apr 2023 005-92634
4 Open 4 document View SEC filing for 4 20 Apr 2023 18 Apr 2023
PRE 14A Open PRE 14A document View SEC filing for PRE 14A PRE 14A 18 Apr 2023 07 Jun 2023 001-40505
4 Open 4 document View SEC filing for 4 17 Apr 2023 13 Apr 2023
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 10 Apr 2023 10 Apr 2023 001-40505
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 05 Apr 2023
DEL AM Open DEL AM document View SEC filing for DEL AM DEL AM 03 Apr 2023 333-271008
S-3 Open S-3 document View SEC filing for S-3 S-3 30 Mar 2023 333-271008
S-8 Open S-8 document View SEC filing for S-8 S-8 30 Mar 2023 333-271005
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K 10-K 30 Mar 2023 31 Dec 2022 001-40505
4 Open 4 document View SEC filing for 4 16 Mar 2023 14 Mar 2023
CERT Open CERT document View SEC filing for CERT 16 Mar 2023 001-40505
25 Open 25 document View SEC filing for 25 25 16 Mar 2023 001-40505
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 16 Mar 2023 005-92634
8-A12B/A Open 8-A12B/A document View SEC filing for 8-A12B/A 8-A12B/A 16 Mar 2023 001-40505
3 Open 3 document View SEC filing for 3 13 Mar 2023 03 Mar 2023
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A AMENDMENT NO. 3 13 Mar 2023 005-92634
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 13 Mar 2023 13 Mar 2023 001-40505
4 Open 4 document View SEC filing for 4 08 Mar 2023 27 Feb 2023
3 Open 3 document View SEC filing for 3 08 Mar 2023 01 Jan 2023
SC 13D Open SC 13D document View SEC filing for SC 13D AMBRX BIOPHARMA INC. 08 Mar 2023 005-92634
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Mar 2023 05 Mar 2023 001-40505
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 03 Mar 2023 005-92634
3 Open 3 document View SEC filing for 3 03 Mar 2023 23 Feb 2023
SC 13G Open SC 13G document View SEC filing for SC 13G 03 Mar 2023 005-92634
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 01 Mar 2023 01 Mar 2023 001-40505
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 27 Feb 2023 005-92634
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 24 Feb 2023 22 Feb 2023 001-40505
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 17 Feb 2023 16 Feb 2023 001-40505
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 14 Feb 2023 005-92634
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 14 Feb 2023 005-92634
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A AMBRX BIOPHARMA INC. 14 Feb 2023 005-92634
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 13 Feb 2023 005-92634
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A AMBRX BIOPHARMA INC. 09 Feb 2023 005-92634
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 09 Feb 2023 005-92634
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Feb 2023 06 Feb 2023 001-40505
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 31 Jan 2023 27 Jan 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 31 Jan 2023 27 Jan 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 31 Jan 2023 27 Jan 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 31 Jan 2023 27 Jan 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 31 Jan 2023 27 Jan 2023
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 30 Jan 2023 27 Jan 2023 001-40505
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 09 Jan 2023 01 Jan 2023
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Jan 2023 01 Jan 2023
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Jan 2023 01 Jan 2023
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Jan 2023 01 Jan 2023
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Jan 2023 01 Jan 2023
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Jan 2023 01 Jan 2023
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Jan 2023 01 Jan 2023
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Jan 2023 01 Jan 2023
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Jan 2023 01 Jan 2023
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Jan 2023 01 Jan 2023
SC 13G Open SC 13G document View SEC filing for SC 13G 19 Dec 2022 005-92634
6-K Open 6-K document View SEC filing for 6-K 6-K 16 Dec 2022 16 Dec 2022 001-40505
6-K Open 6-K document View SEC filing for 6-K 6-K 13 Dec 2022 13 Dec 2022 001-40505
6-K Open 6-K document View SEC filing for 6-K 6-K 01 Nov 2022 01 Nov 2022 001-40505
6-K Open 6-K document View SEC filing for 6-K FORM 6-K 18 Oct 2022 18 Oct 2022 001-40505
6-K Open 6-K document | Open XBRL data View SEC filing for 6-K 6-K 29 Aug 2022 30 Jun 2022 001-40505
6-K Open 6-K document View SEC filing for 6-K 6-K 29 Aug 2022 29 Aug 2022 001-40505
6-K Open 6-K document View SEC filing for 6-K FORM 6-K 16 Aug 2022 16 Aug 2022 001-40505
EFFECT Open EFFECT document View SEC filing for EFFECT 05 Aug 2022 333-266404
424B5 Open 424B5 document View SEC filing for 424B5 424B5 05 Aug 2022 333-266404
CORRESP Open CORRESP document View SEC filing for CORRESP 03 Aug 2022
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 02 Aug 2022
F-3 Open F-3 document View SEC filing for F-3 F-3 29 Jul 2022 333-266404
6-K Open 6-K document View SEC filing for 6-K 6-K 05 Jul 2022 05 Jul 2022 001-40505
6-K Open 6-K document View SEC filing for 6-K 6-K 06 Jun 2022 06 Jun 2022 001-40505
6-K Open 6-K document View SEC filing for 6-K 6-K 17 May 2022 17 May 2022 001-40505
S-8 Open S-8 document View SEC filing for S-8 S-8 26 Apr 2022 333-264490
20-F Open 20-F document | Open XBRL data View SEC filing for 20-F 20-F 26 Apr 2022 31 Dec 2021 001-40505
6-K Open 6-K document View SEC filing for 6-K 6-K 26 Apr 2022 26 Apr 2022 001-40505
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 10 Mar 2022 005-92634
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 14 Feb 2022 005-92634
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SCHEDULE 13G/A 11 Feb 2022 005-92634
SC 13G Open SC 13G document View SEC filing for SC 13G 09 Feb 2022 005-92634
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 08 Feb 2022 005-92634
6-K Open 6-K document View SEC filing for 6-K 6-K 07 Feb 2022 07 Feb 2022 001-40505
SC 13G Open SC 13G document View SEC filing for SC 13G AMBRX BIOPHARMA INC. 18 Jan 2022 005-92634
6-K Open 6-K document View SEC filing for 6-K 6-K 04 Jan 2022 04 Jan 2022 001-40505
6-K Open 6-K document View SEC filing for 6-K 6-K 09 Dec 2021 09 Dec 2021 001-40505
6-K Open 6-K document View SEC filing for 6-K 6-K 22 Nov 2021 22 Nov 2021 001-40505
6-K Open 6-K document View SEC filing for 6-K 6-K 08 Nov 2021 08 Nov 2021 001-40505
6-K Open 6-K document View SEC filing for 6-K FORM 6-K 28 Oct 2021 28 Oct 2021 001-40505
6-K Open 6-K document View SEC filing for 6-K 6-K 28 Oct 2021 28 Oct 2021 001-40505
6-K Open 6-K document View SEC filing for 6-K 6-K 04 Oct 2021 04 Oct 2021 001-40505
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 12 Jul 2021 005-92634
6-K Open 6-K document View SEC filing for 6-K 6-K 02 Jul 2021 30 Jun 2021 001-40505
SC 13G Open SC 13G document View SEC filing for SC 13G 02 Jul 2021 005-92634
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 02 Jul 2021 005-92634
S-8 Open S-8 document View SEC filing for S-8 S-8 22 Jun 2021 333-257264
424B4 Open 424B4 document View SEC filing for 424B4 424B4 21 Jun 2021 333-256639
EFFECT Open EFFECT document View SEC filing for EFFECT 17 Jun 2021 333-256765
EFFECT Open EFFECT document View SEC filing for EFFECT 17 Jun 2021 333-256639
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 17 Jun 2021
CERT Open CERT document View SEC filing for CERT NYSE CERTIFICATION 16 Jun 2021 001-40505
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 15 Jun 2021 001-40505
CORRESP Open CORRESP document View SEC filing for CORRESP 15 Jun 2021
CORRESP Open CORRESP document View SEC filing for CORRESP 15 Jun 2021
CORRESP Open CORRESP document View SEC filing for CORRESP 14 Jun 2021
F-1/A Open F-1/A document View SEC filing for F-1/A F-1/A 14 Jun 2021 333-256639
F-6/A Open F-6/A document View SEC filing for F-6/A F-6/A 14 Jun 2021 333-256765
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 10 Jun 2021
F-6 Open F-6 document View SEC filing for F-6 F-6 04 Jun 2021 333-256765
CORRESP Open CORRESP document View SEC filing for CORRESP 28 May 2021
F-1 Open F-1 document View SEC filing for F-1 F-1 28 May 2021 333-256639
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 25 Mar 2021
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 22 Mar 2021
DRS/A Open DRS/A document View SEC filing for DRS/A 15 Mar 2021 377-04163
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 12 Mar 2021
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 03 Mar 2021
DRS Open DRS document View SEC filing for DRS 03 Feb 2021 377-04163

About this filer

Ambrx Biopharma Cayman, Inc. files with the SEC under CIK 0001836056. This page aggregates EDGAR filings and related ownership activity.

Industry: Biological Products, (No Disgnostic Substances).

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages